Berlin, April 10, 2025 -Cantourage Group SE (hereinafter “Cantourage”, ISIN: DE000A3DSV01,www.cantourage.com), Europe's leading listed medical cannabis company, has completed the strongest quarter in its history: In the first quarter of 2025, the company generated revenues EUR 25.6 million - a new record.

In March 2025, the Berlin-based company also generated double-digit monthly sales for the first time: at over EUR 10.7 million, the previous record from December 2024 (EUR 8.5 million) was significantly exceeded.

Demand for Cantourage cannabis flowers continues to grow significantly

The continued strong increase indemand for Cantourage cannabis flowers is clearly reflected in the company's sales performance: In 2024 as a whole, the company generated sales revenues of EUR 51.4 million, which corresponds to an increase of 118 percent compared tothe previous year (2023: EUR 23.6 million).

‍

Press contact at Cantourage:

Manuel Taverne| taverne@cantourage.com